U.S. federal trademark · Serial No. 98347552
Biological preparations for the treatment of cancer identifying highly specific and potent T-cell receptors used against endogenously presented oncogenic driver peptides; Chemical reagents for medical purposes
Medical and scientific research in the field of analysis and treatment of cancer utilizing T-cells
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.